Shanglin Jin

5PUBLICATIONS
12CO-AUTHORS
Environmental epidemiologyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 08, 2026
Efficacy and Safety of 590 Nm and 590/630 Nm Light-Emitting Diode Therapy for Sensitive Skin: A Prospective Randomized Controlled Trial.

Xuanxuan He, Muyang He, Xuchao Wang

|Mar 07, 2026
Treatment of disseminated refractory primary cutaneous marginal zone lymphoma with orelabrutinib.

Qian Wang, ZiQi Liu, ShangLin Jin

|Oct 17, 2025
Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Zhongyi Xu, Yijie Xuan, Zhe Zhu

|Aug 22, 2024
Photobiomodulation Using 830 nm Lighting-Emitting Diode Inhibits Melanogenesis via FOXO3a in Human Melanocyte.

Yanjun Dan, Li Chen, Shanglin Jin

|Feb 26, 2022
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo.

Xiuyi Wu, Shanglin Jin, Yiwen Yang

Pageof 1

Frequent Collaborators

4 joint publications

Chengfeng Zhang

2 joint publications

Zhongyi Xu

2 joint publications

Leihong Xiang

2 joint publications

Xuanxuan He